Open Access

Aortic sclerosis outcome in the elderly

  • Richard Venn
Critical Care19991:1284

https://doi.org/10.1186/ccf-1999-1284

Published: 3 August 1999

Keywords

Acute chest pain cardiac troponin CK-MB cTnT myocardial injury

Comments

The Cardiovascular Health Study is a prospective study revealing important results as a consequence of the size of the study. Aortic sclerosis has traditionally been described as a benign condition and text books have been consistently reassuring about the clinical findings of a soft ejection murmur with normal character to the carotid pulse. In contrast, this study shows that aortic sclerosis appears to be a marker of coronary artery disease, and its presence may direct the physician to the need for further cardiac investigations. The pathophysiology is difficult to explain at present and awaits further investigation, but the epidemiology is convincing and aortic sclerosis should no longer be thought of as a trivial finding.

Introduction

It has long been felt that, in the absence of ventricular outflow tract obstruction, aortic sclerosis is a benign pathology. It can be characterized clinically by a soft ejection systolic murmur and normal carotid pulses. It affects approximately 25% of those over 65 years old, rising to nearly 50% in those over 85 years of age, compared with the very much lower incidence of hemodynamically important aortic stenosis (4% if > 85 years old), which of course carries a much poorer prognosis. The Cardiovascular Health Study prospectively followed 5888 people over the age of 65 years in the USA, in order has been able to examine whether aortic sclerosis really is a benign condition, or perhaps just one end of the spectrum of aortic valve disease.

Aims

To determine whether aortic sclerosis (diagnosed by echocardiography) is associated with cardiovascular morbidity and mortality.

Methods

The Cardiovascular Health Study prospectively followed two separate groups of subjects over the aged 65 or greater (a total of 5888 patients) during a one year period. Detailed history and examination accompanied by laboratory investigations, including hematology, biochemistry and echocardiography, were performed at baseline. Aortic sclerosis and stenosis were defined at baseline by certain echo characteristics. Coronary artery disease was defined at baseline if there was a history of myocardial infarction, angina, coronary artery bypass graft (CABG), or angioplasty. The mean follow-up period was five years for all subjects, and statistical analysis included identifying those factors already known to be related to aortic sclerosis or stenosis at baseline (age, gender, hypertension, smoking, raised cholesterol, and diabetes).

Results

Echocardiography revealed 3919 patients (70%) with normal valves, 1610 (29%) with sclerosis and 92 (2%) with stenosis. There was a significant progressive increase in all deaths, cardiovascular deaths, and cardiovascular events when comparing normal to sclerotic to stenotic aortic valves (see Table).

Event Rates in the Three Groups

Event

Normal Aortic Valves (N=3919)

Aortic Sclerosis (N=1610)

Aortic Stenosis (N=92)

P Value for Trend

number (percent)

Death from any cause

583 (14.9)

353 (21.9)

38 (41.3)

<0.001

Death from cardiovascular causes

238 (6.1)

162 (10.1)

18 (19.6)

<0.001

Myocardial infraction

217 (6.0)

123 (8.6)

9 (11.3)

<0.001

Angina

358(11.0)

160 (13.0)

17 (24.3)

0.001

Congestive heart failure

337 (8.9)

192 (12.6)

21 (24.7)

<0.001

Stroke

238 (6.3)

122 (8.0)

10 (11.6)

0.003

The risk of death from cause, including cardiovascular, was still greater in patients with a sclerotic compared to a normal valve, even when adjustments were made for factors known to be associated with cardiovascular morbidity and mortality. Those subjects without coronary artery disease at baseline and who had aortic sclerosis had a relative risk of 1.40 for myocardial infarction compared to those with normal valves, when adjusted for the baseline factors described above.

Discussion

Aortic sclerosis, described by echocardiography, carries an increased cardiovascular morbidity and mortality, and this was particularly pronounced in those people who did not have clinical evidence of coronary artery disease at baseline. The development of clinically relevant outflow tract obstruction to explain these findings is unlikely, although no data are available on subsequent progression of valve pathology. Infective endocarditis was not specifically correlated with aortic sclerosis in this study, but significant endocarditis causing morbidity and mortality would surely have been documented. Finally although the pathophysiologies of aortic valve disease and coronary artery disease have similarities, there are many reasons why it is unlikely that aortic sclerosis directly causes myocardial infarction, and so sclerosis may just be a marker of poor outcome from cardiovascular events.

Additional information

An editorial accompanies this article.

References

  1. Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS: Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med. 1999, 341: 142-147.PubMedView ArticleGoogle Scholar

Copyright

© Current Science Ltd 1999